CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications

Author(s):  
H. Seno ◽  
M. Oshima ◽  
M.-A. Taniguchi ◽  
K. Usami ◽  
T.-O. Ishikawa ◽  
...  
2007 ◽  
Vol 38 (1) ◽  
pp. 66-71 ◽  
Author(s):  
Hirotsugu Sakamoto ◽  
Hiroyuki Mutoh ◽  
Kenichi Ido ◽  
Kiichi Satoh ◽  
Hiroko Hayakawa ◽  
...  

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 2-3
Author(s):  
Marialuisa Lugaresi ◽  
Benedetta Mattioli ◽  
Valentina Tassi ◽  
Niccolò Daddi ◽  
Alberto Ruffato ◽  
...  

Abstract Background In Siewert type II adenocarcinoma we investigated the relationship between adenocarcinoma subtypes and survival, histologic/biologic patterns related to the presence/absence of gastric greater curvature metastases. Methods 154 patients who underwent primary transthoracic esophageal resection, total gastrectomy, thoracic-abdominal lymphadenectomy according to a research prospective protocol were considered. Cases were categorized in intestinal and diffuse subtypes, in Barrett's-like, cardiopyloric-like, and gastric-like adenocarcinoma according to the presence/absence of intestinal metaplasia in esophagus and stomach. Cancer specific survival and gastric greater curvature metastases were studied in those categories. Results Pathological stage (7th TNM ed) was IA-IIA in 11%; IIB in 15.6%; IIIA-IV in 73.4%. Cases were: 59% intestinal-type, 41% diffuse-type; Barrett's-type 1.3%, cardiopyloric-type 65%, gastric-type 33.7%. Greater gastric curvature lymph node metastases were detected in 22%, in stage IIIa-IV only, intestinal type 47%; diffuse type 53%. The number of metastatic lymph nodes at station 4 was higher in cardiopyloric-like than in gastric-like type (P < .0001).Five years cancer-specific survival of 154 cases was 40.5%, 59.4.% for intestinal type, 0% for diffuse type; 5-year cancer-specific survival in the absence/presence of greater gastric curvature metastases was respectively 48.7% and 14.9%, for intestinal type it was 67.4% and 27.9%. Histological subtype was an independent prognostic factor. Conclusion The radical difference of 5 year survival between intestinal and diffuse types of Siewert type II adenocarcinoma after primary surgery, the relevant frequency and biologic patterns of station 4 nodal metastases do require further investigation in light of current indications for neoadjuvant therapy and total gastrectomy. Disclosure All authors have declared no conflicts of interest.


2011 ◽  
Vol 26 (5) ◽  
pp. 647 ◽  
Author(s):  
Jung Mook Kang ◽  
Byoung Hwan Lee ◽  
Nayoung Kim ◽  
Hye Seung Lee ◽  
Hee Eun Lee ◽  
...  

2007 ◽  
Vol 20 (12) ◽  
pp. 1286-1297 ◽  
Author(s):  
Qiang Liu ◽  
Ming Teh ◽  
Kosei Ito ◽  
Nilesh Shah ◽  
Yoshiaki Ito ◽  
...  

2020 ◽  
Vol 8 (A) ◽  
pp. 947-955
Author(s):  
Noha Helal ◽  
Zeinab Omran ◽  
Tarek Aboushousha ◽  
Magdy Youssef ◽  
Afkar Badawy ◽  
...  

BACKGROUND: Worldwide gastric cancer (GC) ranks sixth in incidence and second in mortality among all malignancies. CDX2 has an essential role in the development and maintenance of intestinal differentiation in the gut and ectopic sites such as intestinal metaplasia (IM) of the stomach. SOX2 contributes to the cell lineages normally found in the stomach, suggesting contribution in gastric differentiation. AIM: The aim of the study was to assess the expression of CDX2 and SOX2 in chronic gastritis (CG) lesions associated with Helicobacter pylori, IM, or dysplasia as well as in intestinal-type GC. METHODS: Immunohistochemical staining for CDX2 and SOX2 were applied on archival paraffin blocks from 80 CG cases, 40 intestinal-type GC cases, and 10 controls. CG cases were either of non-specific inflammation or associated with H. pylori infection. GC cases were of intestinal-type only, excluding any other type of GC. Control cases were of minimal gastritis, negative for H. pylori, IM, and dysplasia. RESULTS: CDX2 expression was correlated with CG associated with H. pylori, IM, and dysplasia as well as with more differentiated and less invasive pattern of intestinal-type GC, while SOX2 expression was correlated with CG negative for H. pylori and IM as well as with less differentiated and more invasive intestinal-type GC. CONCLUSION: Both CDX2 and SOX2 could predict the behavior of CG disease over time and plan the suitable line of treatment and both proteins could be potential targets for novel therapeutic interventions.


2004 ◽  
Vol 128 (2) ◽  
pp. 218-221
Author(s):  
Francisco Rivera-Hueto ◽  
Encarnación Lag-Asturiano ◽  
JoséC. Utrilla-Alcolea ◽  
Juan M. Herrerías-Gutiérrez

Abstract An unusual case of synchronous gastric carcinomas occurred in a 28-year-old man with a family history of gastric disease. Two tumor foci were identified: a well-differentiated advanced carcinoma with the phenotypic properties of complete intestinal metaplasia and an early intestinal-type carcinoma. Histochemical and immunohistochemical stains to demonstrate complete intestinal metaplasia, ie, Alcian blue pH 2.5/periodic acid–Schiff, high iron diamine/Alcian blue pH 2.5, CD10, and MUC2, were all positive in the advanced adenocarcinoma. Of all markers used, only high iron diamine/Alcian blue pH 2.5 and Alcian blue pH 0.5 were positive in the early carcinoma. In these cases, mistakes frequently are made during examination of endoscopic biopsies. Fortunately, the advanced adenocarcinoma was low grade (the patient has shown no signs of disease at 6 years postsurgery). Histopathologic, histochemical, and immunohistochemical findings suggest that an extensive substrate of complete intestinal metaplasia (corpus) and of complete and incomplete intestinal metaplasia (antrum) can be associated with two independent tumors with different phenotypes.


Apmis ◽  
2021 ◽  
Author(s):  
Sannia Sjöstedt ◽  
Ane Yde Schmidt ◽  
Filipe Garrett Vieira ◽  
Nina Claire Woller ◽  
Finn Cilius Nielsen ◽  
...  

2009 ◽  
Vol 23 (1) ◽  
pp. 54-61 ◽  
Author(s):  
Do Youn Park ◽  
Amitabh Srivastava ◽  
Gwang Ha Kim ◽  
Mari Mino-Kenudson ◽  
Vikram Deshpande ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document